We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Lung Cancer

Journal Scan / Consensus and Guidelines · March 03, 2021

Therapy for Stage IV NSCLC With Driver Alterations

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
J. Clin. Oncol 2021 Feb 16;[EPub Ahead of Print], NH Hanna, AG Robinson, S Temin, S Baker, JR Brahmer, PM Ellis, LE Gaspar, RY Haddad, PJ Hesketh, D Jain, I Jaiyesimi, DH Johnson, NB Leighl, PR Moffitt, T Phillips, GJ Riely, R Rosell, JH Schiller, BJ Schneider, N Singh, DR Spigel, J Tashbar, G Masters

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading